120 related articles for article (PubMed ID: 30023090)
1. Mesothelioma diagnosis and prognosis, are we moving beyond histology and performance status towards circulating biomarkers?
Røe OD
J Thorac Dis; 2018 Jun; 10(Suppl 17):S1956-S1961. PubMed ID: 30023090
[No Abstract] [Full Text] [Related]
2. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
[TBL] [Abstract][Full Text] [Related]
3. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
Antman K; Shemin R; Ryan L; Klegar K; Osteen R; Herman T; Lederman G; Corson J
J Clin Oncol; 1988 Jan; 6(1):147-53. PubMed ID: 3335886
[TBL] [Abstract][Full Text] [Related]
4. Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation.
Ferrari L; Carugno M; Mensi C; Pesatori AC
Front Oncol; 2020; 10():445. PubMed ID: 32318342
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma: a population-based study of survival.
Milano MT; Zhang H
J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of histologic subtyping of malignant pleural mesothelioma.
Brcic L; Kern I
Transl Lung Cancer Res; 2020 Jun; 9(3):924-933. PubMed ID: 32676358
[TBL] [Abstract][Full Text] [Related]
7. Population based epidemiology and prognosis of mesothelioma in Leeds, UK.
Chapman A; Mulrennan S; Ladd B; Muers MF
Thorax; 2008 May; 63(5):435-9. PubMed ID: 18202164
[TBL] [Abstract][Full Text] [Related]
8. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
Sterman DH; Albelda SM
Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A review.
Ahmadzada T; Kao S; Reid G; Clarke S; Grau GE; Hosseini-Beheshti E
Crit Rev Oncol Hematol; 2020 Jun; 150():102949. PubMed ID: 32330840
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in malignant mesothelioma.
Burgers JA; Damhuis RA
Lung Cancer; 2004 Aug; 45 Suppl 1():S49-54. PubMed ID: 15261434
[TBL] [Abstract][Full Text] [Related]
11. Malignant mesothelioma: a review of 35 cases with diagnosis and prognosis.
Griffiths MH; Riddell RJ; Xipell JM
Pathology; 1980 Oct; 12(4):591-603. PubMed ID: 7465255
[TBL] [Abstract][Full Text] [Related]
12. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ
Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in mesothelioma.
Steele JP; Klabatsa A; Fennell DA; Palläska A; Sheaff MT; Evans MT; Shamash J; Rudd RM
Lung Cancer; 2005 Jul; 49 Suppl 1():S49-52. PubMed ID: 15894403
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in mesothelioma.
Arnold DT; Maskell NA
Ann Clin Biochem; 2018 Jan; 55(1):49-58. PubMed ID: 29058958
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters.
Nowak AK; Francis RJ; Phillips MJ; Millward MJ; van der Schaaf AA; Boucek J; Musk AW; McCoy MJ; Segal A; Robins P; Byrne MJ
Clin Cancer Res; 2010 Apr; 16(8):2409-17. PubMed ID: 20371686
[TBL] [Abstract][Full Text] [Related]
16. PATHOLOGY AND SURVIVAL IN TESTICULAR NEOPLASIA.
HALLEY JB
Cancer; 1963 Oct; 16():1269-80. PubMed ID: 14074210
[No Abstract] [Full Text] [Related]
17. Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.
Bruno F; Baratti D; Martinetti A; Morelli D; Sottotetti E; Bonini C; Guaglio M; Kusamura S; Deraco M
Eur J Surg Oncol; 2018 Jun; 44(6):792-798. PubMed ID: 29503128
[TBL] [Abstract][Full Text] [Related]
18. Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma.
Weyn B; Van De Wouwer G; Koprowski M; Van Daele A; Dhaene K; Scheunders P; Jacob W; Van Marck E
J Pathol; 1999 Dec; 189(4):581-9. PubMed ID: 10629562
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-based prognostic indices in malignant pleural mesothelioma.
Pinato DJ; Mauri FA; Ramakrishnan R; Wahab L; Lloyd T; Sharma R
J Thorac Oncol; 2012 Mar; 7(3):587-94. PubMed ID: 22307011
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
